Mettler-Toledo International Inc (MTD)
割高ファンダメンタル
62
株価
$1486.44
時価総額
$30.96B
パート1 · 企業の価値
概要
Mettler-Toledo International Inc. manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other Operations. The company offers laboratory instruments, such as laboratory balances, liquid pipetting solutions, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, density and refractometry instruments, and thermal analysis systems; and other analytical instruments, including UV/VIS spectrophotometers, moisture analyzers, and cell counters, as well as LabX, a laboratory software platform to manage and analyze data generated by its instruments and automate workflows. It also provides industrial instruments comprising industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detectors, x-ray systems, checkweighers, and camera-based imaging equipment. In addition, the company offers retail weighing solutions consisting of weighing and software solutions, AI-driven image recognition solutions for fresh goods, and automated packaging and labeling solutions for the meat backroom. The company serves pharmaceutical and biotech companies, independent research organizations, and testing labs; food manufacturers and retailers; chemical, specialty chemicals, and cosmetics companies; transportation and logistics, metals, and electronics industries; and academic community through its direct sales force and indirect distribution channels. Mettler-Toledo International Inc. was incorporated in 1991 and is headquartered in Greifensee, Switzerland.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
Generated on 2026年9月19日 with claude-haiku-4-5 — shared with all users
Thermo Fisher supplies the same laboratory customers with overlapping lines of analytical instruments, pipettes and process analytics, and competes for the large multi-year supply contracts of pharmaceutical and biotech labs.
Agilent competes for the same analytical-chemistry budget in pharmaceutical and industrial quality-control labs, with chromatography, spectroscopy and lab software that substitute for Mettler-Toledo's analytical instruments.
Waters sells chromatography, mass spectrometry and thermal-analysis systems to the same regulated pharmaceutical and materials laboratories where Mettler-Toledo places its thermal analysis and titration instruments.
Through its life-sciences and diagnostics brands Danaher bids for the same laboratory and bioprocessing equipment, consumables and service contracts, often bundling them across global accounts.
Sartorius is the closest head-to-head rival in laboratory weighing, selling analytical and precision balances, pipettes and lab consumables to the same pharmaceutical, chemical and academic laboratories.
Shimadzu builds balances, moisture analyzers and analytical instruments for the same industrial and laboratory customers, and is the main rival for Mettler-Toledo in Japan and much of Asia.
貸借対照表と流動性
売上高
$4.13B
直近12か月（2026/6/30まで）
純利益
$906M
直近12か月（2026/6/30まで）
フリーキャッシュフロー
$849M
自己資本合計
$-24M
負債合計
$3.74B
流動比率
1.12
利払い倍率
-
負債/EBITDA
1.66
一株当たり利益（EPS）
売上高と純利益
フリーキャッシュフロー
収益内訳
財務推移表
利益率の推移
負債の推移
負債の重さ
成長率グリッド
成長率 — 売上高
適正価値の推定
適正価値
$1181.36
現在株価
$1486.44
安全マージン
-25.8%
適正価値レンジ
$820.70 - $1542.03
使用した評価手法間のばらつきであり、統計的に較正された信頼区間ではありません。
推定方法
バリュエーション指標
P/E レシオ
34.06
ROE
-3677.4%
P/B レシオ
2360.93
P/FCF
35.04
粗利益率
60.3%
ROIC
-
収益性レーダー
価値創造（経済的モート）
ROIC
-
WACC
10.6%
ROIC − WACC
-
ファンダメンタル分析基準
合格（17）
- EPS shows upward trend
- EPS CAGR 12.37%
- Price CAGR 11.95%
- Gross Margin 60.3%
- Positive Free Cash Flow
- CapEx intensity
- Current Ratio
- Debt/EBITDA
- Return on Tangible Assets
- ROE 1816.3%
- Revenue Growth 5Y 5.5%
- Analyst Consensus 53% Buy
- Earnings Surprise avg 3.4%
- Earnings Quality (OCF/NI) 1.08
- Share Dilution -3.1%
- Net Margin Trend 21.9% vs 21.5%
- Piotroski F-Score 6/9
不合格（6）
- P/FCF 35.04
- P/B Ratio 2360.93
- Low reliance on intangibles
- Price below Graham Number
- DCF valuation (Overvalued)
- PEG Ratio 3.05
データなし（5）
- ROIC NaN%
- Dividend Payout NaN%
- Debt/Equity ratio
- Operating Margin NaN%
- Interest Coverage
Piotroski F-スコア
まちまちのシグナル：一部の領域に注意が必要
利益の質
高品質：利益はキャッシュに裏付けられている
株式希薄化
株式を買い戻している。株主に友好的
機関投資家の保有
ガバナンス
経営陣
| 氏名 | 役職 | 年齢 |
|---|---|---|
| Mr. Patrick K. Kaltenbach | President & CEO | 62 |
| Mr. Shawn P. Vadala | Chief Financial Officer | 56 |
| Ms. Susan Graham-Bryce | Chief Human Resources Officer | 49 |
| Mr. Marc de La Gueronniere | Head of European & North American Market Organizations | 61 |
| Mr. Richard Wong | Head of Asia/Pacific | 59 |
| Mr. Markus Koepfli | Chief Information Officer | - |
| Mr. Adam William Uhlman | Head of Investor Relations | - |
| Ms. Michelle M. Roe | Chief Legal Officer & Corporate Secretary | 54 |
| Mr. Oliver Wittorf | Head of Product Inspection, Retail & Global Supply Chain | 49 |
| Mr. Gerhard Keller | Head of Process Analytics | 56 |
監査リスク
2
取締役会リスク
1
報酬リスク
6
株主権利リスク
5
パート2 · 株価と買い時
この部分は企業に価値があるかを判断するものではありません。ファンダメンタルズに納得したうえで、いつ買うかを選ぶためのものです。内容：テクニカル分析、ポテンシャル、過去のドローダウン、ガンマエクスポージャー。
業績推移
via SEC EDGAR
Latest News
Recent headlines for MTD, sourced from Markets Gazette.